233 related articles for article (PubMed ID: 30161054)
1. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
[TBL] [Abstract][Full Text] [Related]
2. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Corneal Cross-Linking for Treatment of Fungal Keratitis: Using Confocal Laser Scanning Microscopy on an Ex Vivo Human Corneal Model.
Alshehri JM; Caballero-Lima D; Hillarby MC; Shawcross SG; Brahma A; Carley F; Read ND; Radhakrishnan H
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6367-6373. PubMed ID: 27898982
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Ruban VV; Archana PT; Sundararajan M; Geraldine P; Thomas PA
Mycoses; 2018 Mar; 61(3):159-171. PubMed ID: 29064157
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Zhu Z; Zhang H; Yue J; Liu S; Li Z; Wang L
BMC Ophthalmol; 2018 Mar; 18(1):65. PubMed ID: 29499665
[TBL] [Abstract][Full Text] [Related]
6. Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits.
Awad R; Hafezi F; Ghaith AA; Baddour MM; Awad K; Abdalla M; Sheta E; Sultan GM; Elmassry A
Eur J Ophthalmol; 2022 Jul; 32(4):1907-1914. PubMed ID: 35384782
[TBL] [Abstract][Full Text] [Related]
7. Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.
Aung TT; Chor WHJ; Lynn MN; Chan ASY; Tan DTH; Beuerman RW
Eye Contact Lens; 2020 Sep; 46(5):274-280. PubMed ID: 32134799
[TBL] [Abstract][Full Text] [Related]
8. Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial.
Uddaraju M; Mascarenhas J; Das MR; Radhakrishnan N; Keenan JD; Prajna L; Prajna VN
Am J Ophthalmol; 2015 Jul; 160(1):131-4.e5. PubMed ID: 25841317
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
10. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
[TBL] [Abstract][Full Text] [Related]
11. Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage.
Kalkanci A; Bilgihan K; Ozdemir HB; Yar Saglam AS; Karakurt F; Erdogan M
Mycopathologia; 2018 Apr; 183(2):329-336. PubMed ID: 29043533
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study.
Bilgihan K; Kalkanci A; Ozdemir HB; Yazar R; Karakurt F; Yuksel E; Otag F; Karabicak N; Arikan-Akdagli S
Curr Eye Res; 2016 Aug; 41(8):1050-1056. PubMed ID: 26644282
[TBL] [Abstract][Full Text] [Related]
13. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking.
Galperin G; Berra M; Tau J; Boscaro G; Zarate J; Berra A
Cornea; 2012 Feb; 31(2):176-80. PubMed ID: 22081155
[TBL] [Abstract][Full Text] [Related]
14. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal keratitis caused by Fusarium solani.
Mahmoud YA
Mycoses; 2007 Jan; 50(1):64-70. PubMed ID: 17302751
[TBL] [Abstract][Full Text] [Related]
16. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea.
Dong X; Shi W; Zeng Q; Xie L
Curr Eye Res; 2005 Aug; 30(8):613-20. PubMed ID: 16109640
[TBL] [Abstract][Full Text] [Related]
17. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis.
Wei A; Wang K; Wang Y; Gong L; Xu J; Shao T
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1443-1452. PubMed ID: 31041523
[TBL] [Abstract][Full Text] [Related]
19. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
[TBL] [Abstract][Full Text] [Related]
20. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Behrens-Baumann W; Seibold M; Hofmüller W; Walter S; Haeberle H; Wecke T; Tammer I; Tintelnot K
Ophthalmic Res; 2012; 48(4):171-6. PubMed ID: 22710976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
